Flagship Pioneering, LLC Long-Term Concentrated

CIK: 0001400240 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 16, 2021

Total Value ($000): $5,493,282 (100.0% shares, 0.0% debt)

Holdings (11)

MRNA Moderna Inc 58.7%

Value ($000) $3,225,148 Shares 30,871,524 Est. Cost $16.43 Unrealized +515.6%

— Sigilon Therapeutics Inc 9.1%

Value ($000) $498,089 Shares 10,370,369 Est. Cost $48.03 Unrealized —

— Seres Therapeutics Inc 6.5%

Value ($000) $359,512 Shares 14,673,973 Est. Cost $8.55 Unrealized —

— Rubius Therapeutics Inc 5.3%

Value ($000) $290,671 Shares 38,296,526 Est. Cost $24.00 Unrealized —

— Evelo Biosciences Inc 5.0%

Value ($000) $276,862 Shares 22,900,069 Est. Cost $10.39 Unrealized —

FHTX Foghorn Therapeutics Inc 4.7%

Value ($000) $256,905 Shares 12,674,120 Est. Cost $19.16 Unrealized 0.0%

DNLI Denali Therapeutics Inc 4.2%

Value ($000) $228,687 Shares 2,730,263 Est. Cost $17.97 Unrealized +236.4%

KLDO Kaleido Biosciences Inc 3.2%

Value ($000) $176,183 Shares 19,360,710 Est. Cost $13.03 Unrealized -37.1%

— Codiak Biosciences Inc 1.5%

Value ($000) $84,216 Shares 2,607,303 Est. Cost $32.30 Unrealized —

— Axcella Health Inc 1.2%

Value ($000) $65,126 Shares 12,548,414 Est. Cost $8.17 Unrealized —

— Syros Pharmaceuticals Inc 0.6%

Value ($000) $31,883 Shares 2,938,494 Est. Cost $13.87 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MRNA	Moderna Inc	30,871,524	$3,225,148	58.7%	$16.43	+515.6%	COM	60770K107
—	Sigilon Therapeutics Inc	10,370,369	$498,089	9.1%	$48.03	—	COM	82657L107
—	Seres Therapeutics Inc	14,673,973	$359,512	6.5%	$8.55	—	COM	81750R102
—	Rubius Therapeutics Inc	38,296,526	$290,671	5.3%	$24.00	—	COM	78116T103
—	Evelo Biosciences Inc	22,900,069	$276,862	5.0%	$10.39	—	COM	299734103
FHTX	Foghorn Therapeutics Inc	12,674,120	$256,905	4.7%	$19.16	0.0%	COM	344174107
DNLI	Denali Therapeutics Inc	2,730,263	$228,687	4.2%	$17.97	+236.4%	COM	24823R105
KLDO	Kaleido Biosciences Inc	19,360,710	$176,183	3.2%	$13.03	-37.1%	COM	483347100
—	Codiak Biosciences Inc	2,607,303	$84,216	1.5%	$32.30	—	COM	192010106
—	Axcella Health Inc	12,548,414	$65,126	1.2%	$8.17	—	COM	05454B105
—	Syros Pharmaceuticals Inc	2,938,494	$31,883	0.6%	$13.87	—	COM	87184Q107